A stitch in time: could a device make abdominal closure safer?
NCT ID NCT07766044
First seen Aug 14, 2026 · Last updated Aug 14, 2026
Summary
This trial compares two ways of closing the abdomen after open colorectal surgery: a device-assisted method (SutureTOOL) versus the traditional manual technique. The goal is to see if the device helps reduce the chance of an incisional hernia forming within one year. Participants are adults undergoing elective surgery through a midline incision for colorectal disease. The study also tracks short-term issues like wound infections and wound separation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- A device-assisted closure technique using the SutureTOOL device versus manual closure with standard needle driver and curved needle.
- What this could lead to
- If successful, this could point toward a standardized closure method that reduces incisional hernias and other abdominal wall complications after open colorectal surgery.
- What could go wrong
- This is a single study with a limited number of participants, and results may not apply to all patients. The device may not significantly reduce hernia rates compared to careful manual closure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Helsingborg hospital
RECRUITINGHelsingborg, Skåne County, 251 87, Sweden
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a plasma beam stop colon polyps from coming back?
- Can we predict chemo brain before it happens?
- Your gut bacteria might reveal hidden cancer risk
- Can a smart digital program restore sleep for cancer survivors?
- Can a new infusion drug shrink Hard-to-Treat tumors?
- Double attack on mutant KRAS: can two targeted drugs outsmart resistant cancers?